highly significantP = 0.001
It contains 3.564 folds more risk of developing cervical cancer with a highly significant P value (adjusted OR = 3.564, 95% CI = 1.647–7.713, P = 0.001).
It contains 3.564 folds more risk of developing cervical cancer with a highly significant P value (adjusted OR = 3.564, 95% CI = 1.647–7.713, P = 0.001).
The Arg/Pro heterozygous genotype also confers 2.126 times more odds of developing cervical cancer with a marginally significant P value (adjusted OR = 2.126, 95% CI = 1.181–3.827, P = 0.012).